BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20470302)

  • 1. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice.
    Higashi K; Oda T; Kushiyama T; Hyodo T; Yamada M; Suzuki S; Sakurai Y; Miura S; Kumagai H
    Nephrology (Carlton); 2010 Apr; 15(3):327-35. PubMed ID: 20470302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pioglitazone and candesartan on renal fibrosis and the intrarenal plasmin cascade in spontaneously hypercholesterolemic rats.
    Omasu F; Oda T; Yamada M; Yoshizawa N; Yamakami K; Sakurai Y; Miura S
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1292-8. PubMed ID: 17670902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
    Terashima H; Kato M; Yasumo H; Tsuchida H; Mizuno M; Sada T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F792-801. PubMed ID: 20660018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.
    Sugiyama H; Kobayashi M; Wang DH; Sunami R; Maeshima Y; Yamasaki Y; Masuoka N; Kira S; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2670-80. PubMed ID: 16141465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction.
    Manucha W; Oliveros L; Carrizo L; Seltzer A; Vallés P
    Kidney Int; 2004 Jun; 65(6):2091-107. PubMed ID: 15149322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.
    Han JY; Kim YJ; Kim L; Choi SJ; Park IS; Kim JM; Chu YC; Cha DR
    J Korean Med Sci; 2010 Jan; 25(1):35-41. PubMed ID: 20052345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
    Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice.
    Zhang Y; Wang J; Zhou QD; Zhang CH; Li Q; Huang S; Zhan J; Wang K; Liu YY; Xu G
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):41-47. PubMed ID: 26838738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
    Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
    Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C5 mediates experimental tubulointerstitial fibrosis.
    Boor P; Konieczny A; Villa L; Schult AL; Bücher E; Rong S; Kunter U; van Roeyen CR; Polakowski T; Hawlisch H; Hillebrandt S; Lammert F; Eitner F; Floege J; Ostendorf T
    J Am Soc Nephrol; 2007 May; 18(5):1508-15. PubMed ID: 17389734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
    Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
    Jung KJ; Kim J; Park YK; Yoon YR; Park KM
    Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
    Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
    Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.
    Nishida M; Fujinaka H; Matsusaka T; Price J; Kon V; Fogo AB; Davidson JM; Linton MF; Fazio S; Homma T; Yoshida H; Ichikawa I
    J Clin Invest; 2002 Dec; 110(12):1859-68. PubMed ID: 12488436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
    Benigni A; Zoja C; Tomasoni S; Campana M; Corna D; Zanchi C; Gagliardini E; Garofano E; Rottoli D; Ito T; Remuzzi G
    J Am Soc Nephrol; 2006 Jun; 17(6):1624-32. PubMed ID: 16687628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
    Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
    Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.